ketanserin has been researched along with Anemia in 2 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Malyszko, J | 1 |
| Pawlak, K | 1 |
| Borawski, J | 1 |
| Malyszko, JS | 1 |
| Mysliwiec, M | 2 |
| Azzadin, A | 1 |
| Mysliwiec, J | 1 |
| Wollny, T | 1 |
| Buczko, W | 1 |
2 other studies available for ketanserin and Anemia
| Article | Year |
|---|---|
Effect of ketanserin on platelet function and bleeding time in uremic patients treated with erythropoietin.
Topics: Adult; Anemia; Blood Coagulation; Blood Coagulation Tests; Case-Control Studies; Drug Monitoring; Er | 1995 |
Serotonin is involved in the pathogenesis of hypertension developing during erythropoietin treatment in uremic rats.
Topics: Anemia; Animals; Blood Platelets; Endothelium, Vascular; Erythropoietin; Hypertension; Ketanserin; K | 1995 |